Avatar for LabGenius

Harnessing evolution with AI to develop radically new protein therapeutics

Harnessing evolution with AI to develop radically new protein therapeutics

The discovery of protein therapeutics has historically been highly artisanal relying heavily on humans for both experimental design and execution. This dependence is limiting because, as a species, we’re cognitively incapable of fully grasping the complexity of biological systems.

At LabGenius, we’re pushing at the boundaries of protein engineering through the development of EVA™️ - a smart robotic platform capable of designing, conducting and critically, learning from its own experiments. The learning aspect means that EVA™️ gets continuously smarter as it unpicks the genetic design rules that underpin life. We believe that with this approach, we will transform the discovery of protein therapeutics.
CEO & Founder at @LabGeni_us / @Bbsrc Innovator of the Year / @Forbes 30 under 30 / @SynBioLEAP fellow / Dad.
Total raised

$13.7M

Funded over

2 rounds

Latest round

Series A (Oct 2019)